Literature DB >> 3514442

Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.

E Kita, M Emoto, K Yasui, K Yasui, N Katsui, K Nishi, S Kashiba.   

Abstract

In order to compare the potential of salmonella vaccines prepared from Salmonella typhimurium to provide the longer-lasting protection from the aspects of cell-mediated immunity, groups of mice were immunized with optimal doses of the following preparations: live cells, ribosome-rich extract, acetone-killed cells, and heat-killed cells. At various intervals post-immunization, mouse peritoneal macrophages and splenic T cells were tested for biological activities. The capacity of each vaccine to confer mouse protection against a lethal challenge with S. typhimurium correlated with the degree of macrophage activation engendered by each of them in the early stage of immunization. In the late stage of immunization, the level of mouse protection conferred by each vaccine was found to be based on the capacity of T cells to respond to salmonella antigens, which correlated with the degree of adoptive immunity by T cells. The live-cell and ribosomal vaccines were superior to killed-cell vaccines in inducing the cell-mediated protection. Thus, the longer-lasting immunity provided by the live-cell and ribosomal vaccines can be accounted for by the fact that T cells of mice immunized with both vaccines have the persistent reactivity to salmonella antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514442      PMCID: PMC1453836     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium.

Authors:  R Germanier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

2.  Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice.

Authors:  F M Collins; G B Mackaness
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

3.  Early antibody response in mice to either infection or immunization with Salmonella typhimurium.

Authors:  K Kenny; M Herzberg
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

4.  Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.

Authors:  E Kita; Y Matsuda; K Matsuda; S Kashiba
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

5.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

6.  Effect of synthetic disaccharide-protein conjugate as an immunogen in Salmonella infection in mice.

Authors:  A A Lindberg; L T Rosenberg; A Ljunggren; P J Garegg; S Svensson; N H Wallin
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

7.  Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection.

Authors:  E Kita; S Kashiba
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

8.  Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.

Authors:  S B Svenson; M Nurminen; A A Lindberg
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

9.  Histopathological study of protective immunity against murine salmonellosis induced by killed vaccine.

Authors:  I Nakoneczna; H S Hsu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  6 in total

1.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

2.  Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.

Authors:  S C Oliveira; Y Zhu; G A Splitter
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

3.  Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.

Authors:  Onyinye I Iweala; Donald W Smith; Kabir S Matharu; Isabel Sada-Ovalle; Deanna D Nguyen; Rosemarie H Dekruyff; Dale T Umetsu; Samuel M Behar; Cathryn R Nagler
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

4.  Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein.

Authors:  S C Oliveira; G A Splitter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.

Authors:  E Kita; K Nishi; M Emoto; N Katsui; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

6.  Conversion of Salmonella typhimurium to L-forms contributes to the maintenance of acquired immunity against murine typhoid.

Authors:  E Kita; M Emoto; F Nishikawa; Y Yoshikai; S Kashiba
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.